Ascendis Pharma EPS Basic from Extraordinaries (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

202.91 -0.08 (-0.04%) USD | NASDAQ | Jan 12, 12:00

View EPS Basic from Extraordinaries (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	--
Evaxion AS	--
DBV Technologies SA	--
Cellectis SA	--
Biodexa Pharmaceuticals Plc	--